av/medigene-ag--big.svg

COM:MEDIGENE

Medigene AG

  • Stock

Last Close

1.61

22/11 16:36

Market Cap

33.01M

Beta: -

Volume Today

13.81K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
7.59M
-
13.78M
81.56%
6.81M
50.61%
9.75M
43.20%
11.38M
16.68%
7.75M
31.83%
10.63M
37.12%
8.75M
17.71%
10.46M
19.59%
31.25M
198.64%
6.03M
80.69%
cost of revenue
1.74M
-
2.09M
20.23%
1.10M
47.12%
1.40M
27.11%
1.62M
15.62%
849K
47.62%
383K
54.89%
1.29M
237.34%
1.36M
5.26%
1.98M
45.81%
3.05M
53.96%
gross profit
5.86M
-
11.70M
99.73%
5.71M
51.23%
8.35M
46.31%
9.75M
16.86%
6.91M
29.21%
10.25M
48.43%
7.46M
27.24%
9.10M
22.07%
29.26M
221.48%
2.98M
89.81%
selling and marketing expenses
806K
-
762K
5.46%
899K
17.98%
2.62M
191.88%
1.26M
52.02%
434K
65.53%
260K
40.09%
653K
151.15%
116K
82.24%
80K
31.03%
general and administrative expenses
2.54M
-
2.29M
9.58%
2.27M
1.13%
2.47M
8.91%
2.58M
4.58%
2.75M
6.58%
2.73M
0.94%
3.62M
32.61%
2.82M
21.88%
4.99M
76.81%
selling general and administrative expenses
3.34M
-
3.06M
8.59%
3.17M
3.63%
5.09M
60.87%
3.84M
24.58%
3.19M
17.05%
2.99M
6.28%
4.27M
42.93%
2.94M
31.12%
5.07M
72.55%
8.76M
72.58%
research and development expenses
6.61M
-
7.50M
13.52%
8.53M
13.75%
11.54M
35.28%
14.88M
28.94%
7.21M
51.52%
22.62M
213.63%
22.26M
1.59%
12.80M
42.52%
28.50M
122.70%
10.72M
62.40%
other expenses
4.19M
-
4.03M
3.94%
4.45M
10.51%
2.44M
45.18%
1.93M
20.79%
14.15M
632.56%
4.80M
66.07%
4.26M
11.29%
3.35M
21.34%
4.42M
31.87%
cost and expenses
15.87M
-
16.66M
4.99%
17.25M
3.49%
22.96M
33.15%
24.76M
7.83%
25.58M
3.29%
30.79M
20.38%
32.08M
4.19%
20.45M
36.26%
39.97M
95.49%
22.52M
43.65%
operating expenses
14.14M
-
14.58M
3.12%
16.14M
10.73%
21.56M
33.57%
23.14M
7.33%
24.73M
6.86%
30.41M
22.97%
30.79M
1.25%
19.09M
38.01%
37.99M
99.03%
19.47M
48.75%
interest expense
1.58M
-
1.80M
14.20%
2.98M
65.24%
1.31M
55.85%
1.13M
13.70%
146K
87.13%
450K
208.22%
428K
4.89%
364K
14.95%
659K
81.04%
544K
17.45%
ebitda
-7.20M
-
-3.30M
54.13%
-9.48M
187.16%
-11.80M
24.52%
-10.54M
10.72%
-15.29M
45.06%
-17.10M
11.84%
-21.50M
25.78%
-6.49M
69.81%
13.14M
302.39%
-15.03M
214.39%
operating income
-9.02M
-
-2.88M
68.06%
-10.44M
262.34%
-13.22M
26.60%
-13.39M
1.31%
-17.82M
33.13%
-20.16M
13.11%
-23.33M
15.73%
-9.98M
57.21%
-8.71M
12.72%
-16.49M
89.21%
depreciation and amortization
751K
-
810K
7.86%
944K
16.54%
845K
10.49%
1.27M
49.94%
1.57M
24.07%
3.06M
94.97%
1.83M
40.29%
3.49M
90.93%
21.85M
525.41%
1.46M
93.30%
total other income expenses net
-1.98M
-
-3.03M
52.85%
-2.96M
2.34%
5.86M
298.01%
1.53M
73.90%
821K
46.34%
243K
70.40%
-5.07M
2,186.42%
-298K
94.12%
-659K
121.14%
-102K
84.52%
income before tax
-10.26M
-
-5.91M
42.40%
-13.40M
126.64%
-9.72M
27.46%
-12.94M
33.12%
-17.00M
31.42%
-19.92M
17.14%
-28.40M
42.60%
-10.28M
63.80%
-9.37M
8.84%
-16.59M
77.00%
income tax expense
18K
-
-155K
961.11%
-400K
158.06%
-228K
43%
634K
378.07%
45K
92.90%
44K
2.22%
472K
972.73%
-300K
163.56%
-1.04M
248%
-415K
60.25%
net income
-10.28M
-
-5.76M
44.01%
-13.00M
125.79%
-9.49M
26.98%
-13.57M
42.99%
-17.05M
25.61%
-19.96M
17.09%
-28.88M
44.65%
-9.98M
65.43%
-8.33M
16.56%
-16.18M
94.20%
weighted average shs out
9.63M
-
12.21M
26.78%
16.81M
37.65%
19.95M
18.71%
21.50M
7.76%
23.67M
10.08%
24.56M
3.77%
24.56M
0.01%
24.56M
0%
24.56M
0%
24.56M
0%
weighted average shs out dil
9.63M
-
12.21M
26.78%
16.81M
37.65%
19.95M
18.71%
21.50M
7.76%
23.67M
10.08%
24.56M
3.77%
24.56M
0.01%
24.56M
0%
24.56M
0%
24.56M
0%
eps
-1.07
-
-0.47
56.07%
-0.77
63.83%
-0.48
37.66%
-0.63
31.25%
-0.72
14.29%
-0.81
12.50%
-1.18
45.68%
-0.41
65.25%
-0.34
17.07%
-0.66
94.12%
epsdiluted
-1.07
-
-0.47
56.07%
-0.77
63.83%
-0.48
37.66%
-0.63
31.25%
-0.72
14.29%
-0.81
12.50%
-1.18
45.68%
-0.41
65.25%
-0.34
17.07%
-0.66
94.12%

All numbers in (except ratios and percentages)